Bank of New York Mellon Adjusts MaxCyte Holdings The Bank of New York Mellon Corporation reduced its stake in MaxCyte, Inc. by 2.7% during the fourth quarter. The adjustment reflects a sale of 9,472 shares, leaving the bank with 336,134 shares valued at $1.4 million. MaxCyte’s stock opened trading today at $3.09, reflecting a 0.7% uptick.2